COLLEEN NEWVINE: Open Payments
NPI 1548869860 · BROOMFIELD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $632
Food & beverage: $533Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $84 |
| Janssen Biotech, Inc. | 3 | $69 |
| Eisai Inc. | 3 | $68 |
| Astellas Pharma US Inc | 2 | $46 |
| Aveo Pharmaceuticals, Inc. | 1 | $35 |
| Genmab U.S., Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $23 |
Products named: Nubeqa, Lenvima, Cresemba, FOTIVDA, Epkinly, JAKAFI, VERZENIO, Trodelvy.
Industry payments across CO — which companies pay providers there.
